Medipresso

Medipresso

Private
DaejeonHealthcare & Life Scienceshttps://medipresso.com/

Last Round

Crowdfunding

Nov 1, 2023

Est. Valuation

$13.4M

Total Funding Raised

$2.48M

Company Overview

Medipresso is a food-tech company that produces and sells herbal and traditional Korean tea in capsules compatible with Nespresso machines.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotech Equipment

Business Model

B2C

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

Nespresso compatible capsulesfunctional beveragesautomated compounding devicetea capsulesNespresso for medicinerazor and blade modelpersonalized medicinefood techtraditional medicine automationhealth techB2C e-commercebiotech equipmentsuperfood supplementsAI recommendations

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medipresso Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medipresso Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingNov 1, 2023
Series AJun 1, 2023
VC RoundDec 7, 2021
DebtJan 21, 2021
Pre SeedFeb 6, 2020

Medipresso Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2023

    Raised $335K in a crowdfunding round.

  • Jun 1, 2023

    $1M round led by ROI Investment Partners

Medipresso Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medipresso Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medipresso's valuation, stock price, and market status.

Firmographic Details

HeadquartersDaejeon
Year Founded2018
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.